British biotech Levicept has appointed Eliot Forster as chief executive, with the company’s founder, Simon Westbrook, taking up the role of chief scientific off 30 November 2023
Utah, USA-based biotech Halia Therapeutics has appointed Lisa Shamon as VP of regulatory affairs and Xianne Penny as a senior medical director. 17 November 2023
UK-based eXmoor pharma, a cell and gene therapy (CGT) manufacturing partner, has announced the hiring of Matthew Paterson as the company’s first chief commercia 15 November 2023
Poolbeg Pharma has recruited three new members of its leadership team from Amryt Pharma, a fellow Anglo-Irish drugmaker with the same co-founder that was recent 10 November 2023
Israeli generics giant Teva Pharmaceutical Industries (TLV: TEVA) has reported its latest quarterly financial results against a backdrop of war in its home regi 8 November 2023
American biopharma company Vertex Pharmaceuticals has announced strong third quarter financial results and raised its guidance for product revenues in 2023. 7 November 2023
Thomas Cueni, the director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and secretary of the Biopharmaceutic 6 November 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.